FdaApplication
ANDA 213693
Identifiers
- fda_app_no: ANDA213693
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS INC USA |
| application_type | ANDA |
| approval_date | 2022-02-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACETYLCYSTEINE | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE;INTRAVENOUS |
1 product